Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04238819
Title A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

central nervous system cancer

Advanced Solid Tumor

Therapies

Abemaciclib + Temozolomide

Abemaciclib + Irinotecan + Temozolomide

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.